CAS: 1415390-47-4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | (R)-BPO-27 REF: AN-AG01EOINCAS: 1415390-47-4 | 98% | A consultar | Lun 15 Jul 24 |
 | (R)-BPO-27 REF: TM-T10591LCAS: 1415390-47-4 | 99.1% | A consultar | Jue 18 Jul 24 |
 | (R)-BPO-27 REF: 3D-QGC39047CAS: 1415390-47-4 | Min. 95% | A consultar | Lun 26 Ago 24 |
Ref: AN-AG01EOIN
| 1mg | 277,00 € | ||
| 2mg | 467,00 € | ||
| 10mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 15 de Julio de 2024
(R)-BPO-27
CAS:1415390-47-4
(R)-BPO-27 is an orally active and potent ATP-competitive CFTR inhibitor (IC50: 4 nM) for the …
Fórmula:
C26H18BrN3O6
Pureza:
99.1%
Forma y color:
Solid
Peso molecular:
548.34
Ref: TM-T10591L
| 2mg | 254,00 € |
Entrega estimada en Estados Unidos, el Jueves 18 de Julio de 2024
(R)-BPO-27
CAS:1415390-47-4
(R)-BPO-27 is a membrane permeabilization agent that belongs to the class of enantiomers. It is …
Fórmula:
C26H18BrN3O6
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
548.34 g/mol
Ref: 3D-QGC39047
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 26 de Agosto de 2024
